Dark | Light
# Intellia Therapeutics, Inc (NTLA)

FDA Lifts Clinical Hold on MAGNITUDE-2 Trial, Boosting NTLA Stock. Positive sentiment and insider buying fuel stock price increase.

### About Intellia Therapeutics, Inc
Intellia Therapeutics, Inc. is a biotechnology company focused on developing curative therapeutics using CRISPR gene editing technology.  
Intellia Therapeutics, Inc uses the ticker $NTLA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Intellia Therapeutics, Inc (NTLA) sentiment is up 46.55% from the previous month.
- Intellia Therapeutics, Inc (NTLA) engagements is up 97.36% from the previous month.
- Intellia Therapeutics, Inc (NTLA) posts created is up 113.7% from the previous month.

### Price: $11.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/close.tsv)  
The stock price has seen a notable increase, potentially breaking its trendline, attributed to the FDA lifting the clinical hold on the MAGNITUDE-2 trial, strong recent social sentiment, and insider buying, supported by recent posts indicating significant institutional buying.  

24-Hour: 2.32%
7-Day: -3.5%
30-Day: -5.04%

1-Year High: $28 on 2025-10-20  
1-Year Low: $6.30 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/alt_rank.tsv)  
Intellia Therapeutics, Inc (NTLA) is currently AltRank #1,005 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +581  
[--] Month: [-----] +666  
[--] Months: [-----] +870  
[--] Year: [-----] +498  
1-Year High: [-----] on 2025-02-28  
1-Year Low: [--] on 2025-11-01  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +12  
[--] Months: [--] +7  
[--] Year: [--] +5  
1-Year High: [--] on 2025-05-02  
1-Year Low: [--] on 2025-12-30  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +42%  
[--] Month: [---------] +97%  
[--] Months: [----------] +36%  
[--] Year: [----------] +40%  
1-Year High: [-------] on 2025-10-27  
1-Year Low: [-----] on 2025-12-21  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
News: [--]
X: [------]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -28%  
[--] Month: [-----] +112%  
[--] Months: [-----] +42%  
[--] Year: [------] +56%  
1-Year High: [---] on 2025-10-30  
1-Year Low: [--] on 2025-12-21  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
News: [--]
X: [---]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Intellia Therapeutics, Inc (NTLA) in the last [--] hours which is down 6.90% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] -38%  
[--] Month: [---] +77%  
[--] Months: [-----] +2.20%  
[--] Year: [-----] +157%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-17  

The most influential creators that mention Intellia Therapeutics, Inc in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@GeneInvesting](/creator/twitter/GeneInvesting)     | [--]    | [------]    | [--]    | [-----]       |
| [@ayesha35421](/creator/twitter/ayesha35421)         | [--]    | [--]        | [--]    | [---]         |
| [@shabeezy84](/creator/twitter/shabeezy84)           | [--]    | [--]         | [--]     | [---]         |
| [@AIStockSavvy](/creator/twitter/AIStockSavvy)       | [--]    | [------]    | [--]     | [---]         |
| [@BRSreality](/creator/twitter/BRSreality)           | [--]    | [---]       | [--]    | [---]         |
| [@Tickeron](/creator/twitter/Tickeron)               | [--]    | [------]    | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]    | [---]         |
| [@StockSavvyShay](/creator/twitter/StockSavvyShay)   | [--]    | [-------]   | [--]     | [---]         |
| [@BiomedicalRX](/creator/twitter/BiomedicalRX)       | [--]    | [-----]     | [--]     | [---]         |
| [@PandyAlina45893](/creator/twitter/PandyAlina45893) | [--]   | [---]       | [--]     | [---]         |

[View More](/list/creators/$ntla/100)
  
  
### Sentiment: 82%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/sentiment.tsv)  
Current Value: 82%  
Daily Average: 76%  
[--] Week: 88% +18%  
[--] Month: 85% +27%  
[--] Months: 85% +3%  
[--] Year: 85% +6%  
1-Year High: 97% on 2025-06-27  
1-Year Low: 30% on 2025-05-29  

Most Supportive Themes:
- Gene Therapy Potential: (45%) The long-term potential of gene editing technology, particularly in treating genetic diseases, remains a key supportive theme.
- Company Resilience: (30%) Despite setbacks, some believe in Intellia's ability to overcome challenges and continue developing life-saving treatments.
- Acquisition Opportunities: (15%) The current stock price dip is seen by some as a potential buying opportunity for future growth.
  
Most Critical Themes:
- FDA Clinical Hold: (10%) The FDA's clinical hold on trials due to safety concerns, specifically liver toxicity (Hy's Law), is the primary critical theme.
  
  
  
### Social Dominance: 0.014%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/social_dominance.tsv)  
Current Value: 0.014%  
Daily Average: 0.03%  
[--] Week: 0.011% -0.0005700000000000011%  
[--] Month: 0.024% -0.0076%  
[--] Months: 0.024% +0.006%  
[--] Year: 0.024% -0.0026%  
1-Year High: 0.083% on 2025-11-15  
1-Year Low: 0.0088% on 2025-12-21  
  
  
### Market Dominance: 0.00156%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/market_dominance.tsv)  
Current Value: 0.00156%  
Daily Average: 0%  
1-Year High: 0.00364% on 2025-10-20  
1-Year Low: 0.00098% on 2025-05-30  
  
  
### Market Cap: $1,377,217,820
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ntla/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ntla/time-series/market_cap.tsv)  
Current Value: $1,377,217,820  
Daily Average: $1,227,944,989  
[--] Week: $1,377,217,820 -3.30%  
[--] Month: $1,377,217,820 -1.10%  
[--] Months: $1,377,217,820 +17%  
[--] Year: $1,377,217,820 +40%  
1-Year High: $3,003,565,870 on 2025-10-20  
1-Year Low: $650,089,649 on 2025-04-08  

### Top Intellia Therapeutics, Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Nex-Z $NTLA vs. $ALNY Pros: best data weve ever seen across the board on ALL metrics one and done in 2-4 hour outpatient drip no concern for yearly insurance no variability Cons: rare liver elevations in elderly patients (especially in CM) must be mitigated and lowered as much as possible. RNAi seen as safer with longer track record overall and reversible Nucresiran Pros: could be even higher % KD only 2x per year instead of 4x (Amvuttra/Vutrisiran) reversible Cons: only seen KD data from healthy volunteers 2x per year instead of [--] and done need insurance reauthorizations some worry knocking"  
[X Link](https://x.com/GeneInvesting/status/2022438849520308302) [@GeneInvesting](/creator/x/GeneInvesting) 2026-02-13T22:32Z 15.3K followers, [----] engagements


"Strong recovery and continuation on $BNAI resulting in a 67%+ return. Join other serious traders and trade together 👉 Charts dont rush traders do 📊 Free trial live no card info. Watchlist $RR $ASST $EONR $NTLA $IPW $IVF $BZAI https://discord.com/invite/NHHBU7v9ys https://discord.com/invite/NHHBU7v9ys"  
[X Link](https://x.com/ayesha35421/status/2022369950422163637) [@ayesha35421](/creator/x/ayesha35421) 2026-02-13T17:59Z [--] followers, [---] engagements


"Clear accumulation on $CCHH before the upside expansion. Network with high-level traders 👉 Charts dont scream they whisper 👂📊 Start free trial now $0 to try. Watchlist $RR $ASST $EONR $NTLA $IPW $IVF $BZAI https://discord.com/invite/NHHBU7v9ys https://discord.com/invite/NHHBU7v9ys"  
[X Link](https://x.com/ayesha35421/status/2022364674210386380) [@ayesha35421](/creator/x/ayesha35421) 2026-02-13T17:38Z [--] followers, [---] engagements


"This looks beautiful $HOOD $GME $AMC $BB $KOSS $CLOV $UWMC $OPAD $RDFN $Z $OPEN $COMP $REAL $SKLZ $PLTR $AI $BBAI $SMR $OKLO $LEGN $VIR $BEAM $NTLA $CRSP $TWST $PACB $ILMN $GH $TDOC $LVGO $RXRX $SDGR $ABCL $KYMR $RXRX $VERV $PRME $SANA 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating Co. is building something BIG in the DJ Basin 💥 Explosive revenue EBITDA & production growth 💥 Oil-weighted assets = stronger margins in a rising crude environment 💥 Strategic acquisitions adding https://t.co/nFWsHPltVX 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie"  
[X Link](https://x.com/shabeezy84/status/2022352782561513538) [@shabeezy84](/creator/x/shabeezy84) 2026-02-13T16:50Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Intellia Therapeutics, Inc (NTLA)

FDA Lifts Clinical Hold on MAGNITUDE-2 Trial, Boosting NTLA Stock. Positive sentiment and insider buying fuel stock price increase.

About Intellia Therapeutics, Inc

Intellia Therapeutics, Inc. is a biotechnology company focused on developing curative therapeutics using CRISPR gene editing technology.
Intellia Therapeutics, Inc uses the ticker $NTLA for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Intellia Therapeutics, Inc (NTLA) sentiment is up 46.55% from the previous month.
  • Intellia Therapeutics, Inc (NTLA) engagements is up 97.36% from the previous month.
  • Intellia Therapeutics, Inc (NTLA) posts created is up 113.7% from the previous month.

Price: $11.90

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has seen a notable increase, potentially breaking its trendline, attributed to the FDA lifting the clinical hold on the MAGNITUDE-2 trial, strong recent social sentiment, and insider buying, supported by recent posts indicating significant institutional buying.

24-Hour: 2.32% 7-Day: -3.5% 30-Day: -5.04%

1-Year High: $28 on 2025-10-20
1-Year Low: $6.30 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Intellia Therapeutics, Inc (NTLA) is currently AltRank #1,005 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +581
[--] Month: [-----] +666
[--] Months: [-----] +870
[--] Year: [-----] +498
1-Year High: [-----] on 2025-02-28
1-Year Low: [--] on 2025-11-01

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +12
[--] Months: [--] +7
[--] Year: [--] +5
1-Year High: [--] on 2025-05-02
1-Year Low: [--] on 2025-12-30

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +42%
[--] Month: [---------] +97%
[--] Months: [----------] +36%
[--] Year: [----------] +40%
1-Year High: [-------] on 2025-10-27
1-Year Low: [-----] on 2025-12-21

Engagements by network (24h): Reddit: [--] YouTube: [--] News: [--] X: [------] TikTok: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -28%
[--] Month: [-----] +112%
[--] Months: [-----] +42%
[--] Year: [------] +56%
1-Year High: [---] on 2025-10-30
1-Year Low: [--] on 2025-12-21

Mentions by network (24h): Reddit: [--] YouTube: [--] News: [--] X: [---] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Intellia Therapeutics, Inc (NTLA) in the last [--] hours which is down 6.90% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [---] -38%
[--] Month: [---] +77%
[--] Months: [-----] +2.20%
[--] Year: [-----] +157%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-17

The most influential creators that mention Intellia Therapeutics, Inc in the last [--] hours

Creator Rank Followers Posts Engagements
@GeneInvesting [--] [------] [--] [-----]
@ayesha35421 [--] [--] [--] [---]
@shabeezy84 [--] [--] [--] [---]
@AIStockSavvy [--] [------] [--] [---]
@BRSreality [--] [---] [--] [---]
@Tickeron [--] [------] [--] [---]
@BuyTheUgly [--] [--] [--] [---]
@StockSavvyShay [--] [-------] [--] [---]
@BiomedicalRX [--] [-----] [--] [---]
@PandyAlina45893 [--] [---] [--] [---]

View More

Sentiment: 82%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 82%
Daily Average: 76%
[--] Week: 88% +18%
[--] Month: 85% +27%
[--] Months: 85% +3%
[--] Year: 85% +6%
1-Year High: 97% on 2025-06-27
1-Year Low: 30% on 2025-05-29

Most Supportive Themes:

  • Gene Therapy Potential: (45%) The long-term potential of gene editing technology, particularly in treating genetic diseases, remains a key supportive theme.
  • Company Resilience: (30%) Despite setbacks, some believe in Intellia's ability to overcome challenges and continue developing life-saving treatments.
  • Acquisition Opportunities: (15%) The current stock price dip is seen by some as a potential buying opportunity for future growth.

Most Critical Themes:

  • FDA Clinical Hold: (10%) The FDA's clinical hold on trials due to safety concerns, specifically liver toxicity (Hy's Law), is the primary critical theme.

Social Dominance: 0.014%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.014%
Daily Average: 0.03%
[--] Week: 0.011% -0.0005700000000000011%
[--] Month: 0.024% -0.0076%
[--] Months: 0.024% +0.006%
[--] Year: 0.024% -0.0026%
1-Year High: 0.083% on 2025-11-15
1-Year Low: 0.0088% on 2025-12-21

Market Dominance: 0.00156%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00156%
Daily Average: 0%
1-Year High: 0.00364% on 2025-10-20
1-Year Low: 0.00098% on 2025-05-30

Market Cap: $1,377,217,820

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,377,217,820
Daily Average: $1,227,944,989
[--] Week: $1,377,217,820 -3.30%
[--] Month: $1,377,217,820 -1.10%
[--] Months: $1,377,217,820 +17%
[--] Year: $1,377,217,820 +40%
1-Year High: $3,003,565,870 on 2025-10-20
1-Year Low: $650,089,649 on 2025-04-08

Top Intellia Therapeutics, Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Nex-Z $NTLA vs. $ALNY Pros: best data weve ever seen across the board on ALL metrics one and done in 2-4 hour outpatient drip no concern for yearly insurance no variability Cons: rare liver elevations in elderly patients (especially in CM) must be mitigated and lowered as much as possible. RNAi seen as safer with longer track record overall and reversible Nucresiran Pros: could be even higher % KD only 2x per year instead of 4x (Amvuttra/Vutrisiran) reversible Cons: only seen KD data from healthy volunteers 2x per year instead of [--] and done need insurance reauthorizations some worry knocking"
X Link @GeneInvesting 2026-02-13T22:32Z 15.3K followers, [----] engagements

"Strong recovery and continuation on $BNAI resulting in a 67%+ return. Join other serious traders and trade together 👉 Charts dont rush traders do 📊 Free trial live no card info. Watchlist $RR $ASST $EONR $NTLA $IPW $IVF $BZAI https://discord.com/invite/NHHBU7v9ys https://discord.com/invite/NHHBU7v9ys"
X Link @ayesha35421 2026-02-13T17:59Z [--] followers, [---] engagements

"Clear accumulation on $CCHH before the upside expansion. Network with high-level traders 👉 Charts dont scream they whisper 👂📊 Start free trial now $0 to try. Watchlist $RR $ASST $EONR $NTLA $IPW $IVF $BZAI https://discord.com/invite/NHHBU7v9ys https://discord.com/invite/NHHBU7v9ys"
X Link @ayesha35421 2026-02-13T17:38Z [--] followers, [---] engagements

"This looks beautiful $HOOD $GME $AMC $BB $KOSS $CLOV $UWMC $OPAD $RDFN $Z $OPEN $COMP $REAL $SKLZ $PLTR $AI $BBAI $SMR $OKLO $LEGN $VIR $BEAM $NTLA $CRSP $TWST $PACB $ILMN $GH $TDOC $LVGO $RXRX $SDGR $ABCL $KYMR $RXRX $VERV $PRME $SANA 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating Co. is building something BIG in the DJ Basin 💥 Explosive revenue EBITDA & production growth 💥 Oil-weighted assets = stronger margins in a rising crude environment 💥 Strategic acquisitions adding https://t.co/nFWsHPltVX 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie"
X Link @shabeezy84 2026-02-13T16:50Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Intellia Therapeutics, Inc (NTLA)
/topic/$ntla